Professor and Chief, Division of General Thoracic Surgery
Baylor College of Medicine
Director, Lung Institute
Baylor College of Medicine
Olga Keith Wiess Chair in Surgery
Baylor College of Medicine
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Board Certifications

American Board of Surgery
American Board of Thoracic Surgery


MD from Cornell University Medical College
Residency at Peter Bent Brigham Hospital
General Surgery
Residency at University of Toronto
Thoracic Surgery
Residency at University of Toronto
Cardiac Surgery
Fellowship at Beth Israel Hospital & Harvard Medical School
Research Fellow in Gastroenterology

David J. Sugarbaker is an internationally recognized thoracic surgeon specializing in the treatment of mesothelioma. He earned his medical degree from Cornell University Medical School and completed a residency in surgery at Brigham and Women’s Hospital. He also completed a residency in cardiothoracic surgery at Toronto General Hospital, where he served as chief resident in both thoracic surgery and cardiac surgery.

Dr. Sugarbaker, who is board certified in surgery and thoracic surgery, leads the Lung Institute at Baylor College of Medicine. He directs the mesothelioma clinical and research program.

Since 1988, Dr. Sugarbaker has focused his career on the treatment of pleural mesothelioma and his contributions have helped countless patients and families with no other options. In 2002, he founded the International Mesothelioma Program with the central goal of finding a cure for this disease. The program is the largest of its kind and attracts patients from all over the world.

In 1989, Dr. Sugarbaker was a leader in the establishment of the Tissue and Blood Repository at Brigham and Women’s Hospital. One of the first tissue repositories in the US, the Tissue and Blood Repository has led to extremely fruitful collaborative research projects. Dr. Sugarbaker has mentored hundreds of residents and fellows during his time at Brigham and Women’s Hospital, a reflection of his deep commitment to teaching the next generation of physicians. His contributions to education also include establishing a unique fellowship in thoracic oncology, a minimally invasive thoracic surgery fellowship, and a visiting scholar program for thoracic surgery.


American Association for Thoracic Surgery
American College of Chest Physicians
American College of Surgeons
American College of Chest Physicians
Esophageal Surgery Club
American Surgical Association
Society of Thoracic Surgeons
International Society for Heart and Lung Transplantation
Society of University Surgeons
Society of Surgical Oncology
Alpha Omega Alpha Honor Medical Society

Honors & Awards

The Pioneer Award
The Chadwick Medal

Selected Publications

  • Mohiuddin K, Haneuse S, Sofer T, Gill R, Jaklitsch MT, Colson YL, Wee J, Bueno R, Mentzer SJ, Sugarbaker DJ, Swanson SJ. "Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non-small cell lung cancer." Thorac Cardiovasc Surg.
  • De Rienzo A, Yeap BY, Cibas ES, Richards WG, Dong L, Gill RR, Sugarbaker DJ, Bueno R. "Gene expression ratio test distinguishes normal lung from lung tumors in solid tissue and FNA biopsies." J Mol Diagn.
  • Chirieac LR, Barletta JA, Yeap BY, Richards WG, Tilleman T, Bueno R, Baldini EH, Godleski J, Sugarbaker DJ. "Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma." J Clin Oncol.
  • Burt BM, Ali SO, DaSilva MC, Yeap BY, Richards WG, Baldini EH, Sugarbaker DJ. "Clinical indications and results after chest wall resection for recurrent mesothelioma." J Thorac Cardiovasc Surg.
  • Jaklitsch MT, Gu L, Demmy T, Harpole DH, D'Amico TA, McKenna RJ, Krasna MJ, Kohman LJ, Swanson SJ, DeCamp MM, Wang X, Barry S, Sugarbaker DJ. CALGB Thoracic Surgeons. "Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803." J Thorac Cardiovasc Surg.
  • Hamaji M, Vanderlaan PA, Sugarbaker DJ, McNamee CJ. "A microthymoma and no germinal centre in myasthenia gravis." Eur J Cardiothorac Surg.
  • Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG. "Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection." J Thorac Cardiovasc Surg.
  • Sugarbaker DJ, Wolf AS, Chirieac LR, Godleski JJ, Tilleman TR, Jaklitsch MT, Bueno R, Richards WG. "Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy." Eur J Cardiothorac Surg.
  • Burt BM, Bader A, Winter D, Rodig SJ, Bueno R, Sugarbaker DJ. "Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation." Clin Cancer Res.
  • Gill RR, Richards WG, Yeap BY, Matsuoka S, Wolf AS, Gerbaudo VH, Bueno R, Sugarbaker DJ, Hatabu H. "Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume." Am J Roentgenol.